<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Drug Alcohol Depend</journal-id><journal-id journal-id-type="iso-abbrev">Drug Alcohol Depend</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Drug and alcohol dependence</journal-title></journal-title-group><issn pub-type="ppub">0376-8716</issn><issn pub-type="epub">1879-0046</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10556849</article-id><article-id pub-id-type="pmcid-ver">PMC10556849.319</article-id><article-id pub-id-type="pmcaid">10556849</article-id><article-id pub-id-type="pmcaiid">10556849</article-id><article-id pub-id-type="manuscript-id">NIHMS1931937</article-id><article-id pub-id-type="pmid">37703770</article-id><article-id pub-id-type="doi">10.1016/j.drugalcdep.2023.110958</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1931937</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1931937</article-id><article-version article-version-type="pmc-version">319</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Potential effect of antidepressants on remission from cocaine use disorder - A nationwide matched retrospective cohort study</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Gao</surname><given-names initials="Z">Zhenxiang</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Winhusen</surname><given-names initials="TJ">T. John</given-names></name><xref rid="A2" ref-type="aff">2</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gorenflo</surname><given-names initials="M">Maria</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ghitza</surname><given-names initials="UE">Udi E.</given-names></name><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Nunes</surname><given-names initials="E">Edward</given-names></name><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Saxon</surname><given-names initials="AJ">Andrew J.</given-names></name><xref rid="A6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Korthuis</surname><given-names initials="T">Todd</given-names></name><xref rid="A7" ref-type="aff">7</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Brady</surname><given-names initials="K">Kathleen</given-names></name><xref rid="A8" ref-type="aff">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Luo</surname><given-names initials="S">Sean</given-names></name><xref rid="A9" ref-type="aff">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Davis</surname><given-names initials="PB">Pamela B.</given-names></name><xref rid="A10" ref-type="aff">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kaelber</surname><given-names initials="DC">David C.</given-names></name><xref rid="A11" ref-type="aff">11</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Xu</surname><given-names initials="R">Rong</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib></contrib-group><aff id="A1"><label>1.</label> Center for Artificial Intelligence in Drug Discovery, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.</aff><aff id="A2"><label>2.</label> Center for Addiction Research, University of Cincinnati College of Medicine, Cincinnati, OH, USA.</aff><aff id="A3"><label>3.</label> Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.</aff><aff id="A4"><label>4.</label> Center for the Clinical Trials Network (CCTN), National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Bethesda, MD, USA.</aff><aff id="A5"><label>5.</label> Department of Psychiatry, New York State Psychiatric Institute, Irving Medical Center, Columbia University, New York, NY, USA</aff><aff id="A6"><label>6.</label> Department of Psychiatry and Behavioral Science, School of Medicine, University of Washington, Seattle, WA, USA.</aff><aff id="A7"><label>7.</label> PTK Affiliation: Addiction Medicine Section, Department of Medicine, Oregon Health &amp; Science University, Portland, Oregon, USA</aff><aff id="A8"><label>8.</label> Department of Psychiatry and Behavioral Sciences, College of Medicine, Medical University of South Carolina, Charleston, SC, USA</aff><aff id="A9"><label>9.</label> Columbia University Division on Substance Use Disorders, and Research Scientist, New York State Psychiatric Institute, New York, NY, USA</aff><aff id="A10"><label>10.</label> Center for Community Health Integration, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.</aff><aff id="A11"><label>11.</label> Center for Clinical Informatics Research and Education, The Metro Health System, Cleveland, Ohio, USA.</aff><author-notes><corresp id="CR1"><label>*</label>Corresponding to: Center for Addiction Research, University of Cincinnati College of Medicine, Cincinnati, OH, USA. <email>winhust@ucmail.uc.edu</email> (T. John Winhusen). Center for Artificial Intelligence in Drug Discovery, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA. <email>rxx@case.edu</email> (Rong Xu)</corresp><fn fn-type="COI-statement" id="FN1"><p id="P28">Conflict of interest</p><p id="P29">The authors declare that they have no conflict of interest.</p></fn></author-notes><pub-date pub-type="ppub"><day>01</day><month>10</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>07</day><month>9</month><year>2023</year></pub-date><volume>251</volume><issue-id pub-id-type="pmc-issue-id">446819</issue-id><fpage>110958</fpage><lpage>110958</lpage><pub-history><event event-type="nihms-submitted"><date><day>03</day><month>10</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>01</day><month>10</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>10</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-10-01 00:25:29.690"><day>01</day><month>10</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1931937.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P1">Cocaine use disorder (CUD) is a significant public health issue for which there is no Food and Drug Administration-approved pharmacotherapy. Depressive disorders are common psychiatric comorbidity amongst individuals with CUD.</p></sec><sec id="S2"><title>Methods:</title><p id="P2">A retrospective cohort study was conducted among 161,544 patients diagnosed with CUD and depression to evaluate the effectiveness of 13 antidepressants on CUD remission. For any antidepressant found to be associated with CUD remission that had an additional indication, we conducted an additional analysis to evaluate the effectiveness of the candidate drug in patients with CUD with that indication. We then analyzed publicly genomic and functional databases to identify potential explanatory mechanisms of action of the candidate drug in the treatment of CUD.</p></sec><sec id="S3"><title>Results:</title><p id="P3">Among these antidepressants, bupropion was associated with higher rates of CUD remission compared to propensity-score matched patients prescribed other antidepressants: hazard ratio (HR) and 95% confidence interval (CI) 1.57 (95% CI: 1.27&#8211;1.94). Bupropion is also approved for smoking cessation. We identified CUD patients with co-occurring nicotine dependence and observed that patients prescribed bupropion displayed a higher rate of CUD remission compared to matched individuals prescribed other drugs for nicotine dependence: 1.38 (95% CI: 1.11&#8211;1.71). Genetic and functional analyses revealed that bupropion interacts with four protein-encoding genes (COMT, DRD2, SLC6A3, and SLC6A4) which are also associated with CUD and targets CUD-associated pathways including serotonergic synapses, cocaine addiction, and dopaminergic synapses.</p></sec><sec id="S4"><title>Conclusions:</title><p id="P4">Our findings suggest that bupropion might be considered a treatment for improving CUD remission in patients with CUD and co-occurring depression or nicotine dependence.</p></sec></abstract><kwd-group><kwd>Cocaine use disorder</kwd><kwd>Antidepressant</kwd><kwd>Bupropion</kwd><kwd>Nicotine dependence</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>